Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.

about

Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.

Item

http://www.wikidata.org/entity/Q55052715

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@en

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@nl

type

Item

label

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@en

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@nl

prefLabel

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@en

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@nl

P1476

Amplification of CD20 Cross-Li ...... e Macromolecular Therapeutics.

@en

P2093

Jiawei Wang

http://www.w3.org/2001/XMLSchema#string

Jiyuan Yang

http://www.w3.org/2001/XMLSchema#string

Lian Li

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.

Global cancer statistics, 2012

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Cancer statistics, 2016

Regulation of cell death: the calcium-apoptosis link

Antigenic modulation and rituximab resistance.

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.

S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine.

Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.

A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections.

P304

3658-3670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSNANO.8B00797

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jindřich Kopeček

P577

2018-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29595951

http://www.w3.org/2001/XMLSchema#string

P921

macromolecule

P932

5916500

http://www.w3.org/2001/XMLSchema#string